ADAM WBC2

This fully automated residual leukocyte counting system is a rapid, high-accuracy analyzer designed for quality control of leukoreduced blood and platelet products in transfusion laboratories and blood banks. Using fluorescent imaging and automated image analysis, it delivers precise rWBC results in just 45 seconds with minimal operator involvement. With FDA 510(k) clearance, strong correlation to flow cytometry, and a simple three-step workflow, the system provides a fast, objective, and standardized solution for transfusion safety compliance.

Please Log In to access Additional Details and documents …

• Residual leukocyte counting for blood products:
  Automated quantification of residual white blood cells in leukoreduced red cell and platelet units to verify transfusion-quality standards.
  
  

• Fast testing performance:
  Delivers complete rWBC results in approximately 45 seconds per test, supporting rapid batch verification in blood banks.
  
  

• Simple three-step workflow:

1. Sample preparation

2. Sample loading

3. Automatic result output
   Designed for routine use by all operator skill levels.
   
   

• Fluorescent imaging cell detection:
  Uses propidium iodide (PI) staining and high-sensitivity CMOS imaging for automated nucleated cell detection and counting.
  
  

• High analytical accuracy:
  Demonstrates strong linear correlation with flow cytometry (r ≈ 0.99), providing flow-comparable performance.
  
  

• Objective, bias-free measurement:
  Fully automated counting eliminates user variability and subjective interpretation associated with manual microscopy.
  
  

• Dedicated reagent and consumable kit:
  Includes standard bead, r-solution, and disposable r-slides with defined sample loading volumes for standardized operation.
  
  

• Compact benchtop design:
  Analyzer dimensions approximately 277 × 276 × 270 mm; weight approx. 7.0 kg; suitable for routine laboratory benches.
  
  

• Connectivity and data export:
  Supports PC connection for data transfer and result archiving.
  
  

• Clinical deployment areas:
  Hospital blood banks
  Transfusion medicine laboratories
  Regional blood centers
  Platelet and RBC product quality control workflows